Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
Open accessThe DOI matches its Crossref record; 186 of the 189 references it cites were found in a registry or an index.
Abstract
An absolute, supraphysiologic elevation in GFR is observed early in the natural history in 10%–67% and 6%–73% of patients with type 1 and type 2 diabetes, respectively. Moreover, at the single-nephron level, diabetes-related renal hemodynamic alterations—as an adaptation to reduction in functional nephron mass and/or in response to prevailing metabolic and (neuro)hormonal stimuli—increase glomerular hydraulic pressure and transcapillary convective flux of ultrafiltrate and macromolecules. This phenomenon, known as glomerular hyperfiltration, classically has been hypothesized to predispose to irreversible nephron damage, thereby contributing to initiation and progression of kidney disease in diabetes. However, dedicated studies with appropriate diagnostic measures and clinically relevant end points are warranted to confirm this assumption. In this review, we summarize the hitherto proposed mechanisms involved in diabetic hyperfiltration, focusing on ultrastructural, vascular, and tubular factors. Furthermore, we review available evidence on the clinical significance of hyperfiltration in diabetes and discuss currently available and emerging interventions that may attenuate this renal hemodynamic abnormality. The revived interest in glomerular hyperfiltration as a prognostic and pathophysiologic factor in diabetes may lead to improved and timely detection of (progressive) kidney disease, and could provide new therapeutic opportunities in alleviating the renal burden in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
Aziz, F., & Chaudhary, K. (2017) · Cardiorenal Medicine · doi:10.1159/000450796 · Cited by 3,267
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation
Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A., & Brenner, B. M. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.241.1.f85 · Cited by 1,680 · cited 1×
“Furthermore, increased GFR in single remnantnephrons — tocompensatefor reduced nephron numbers 8,9 and/or caused by stimuli of the diabetes phenotype — is proposed to accelerate renal function decline in longer-standing diabetes.”
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Self-citationCherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Diabetic kidney disease: a report from an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153 · cited 1×
“…consistently reduce bodyweight and BP, and may in fl uence several vascular mediators of renal hemodynamics in both the fasting and postprandial state ( e.g. , a decrease in atrial natriuretic peptide and insulin, and an increase in glucagon, RAS components, and glucagon-like peptide 1 [GLP – 1]).”
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072 · cited 1×
“Single-Nephron Hyperfiltration and Renal End Points: RAS Blockade Trials Asangiotensin II induces anet increase in postglomerular resistance,71 reducing its action with an angiotensin converting enzyme inhibitor or angiotensin receptor blocker (ARB) lowers FF and PGLO.(72) Consequently, RAS blockers are known to varia…”
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
The hyperfiltration theory: A paradigm shift in nephrology
Brenner, B. M., Lawler, E. V., & Mackenzie, H. S. (1996) · Kidney International · doi:10.1038/ki.1996.265 · Cited by 868 · cited 2×
“8,32 Preferential sites of action of these factors are derived from infusion or blockade studies in preclinical models and humans, in which reduced FF is frequently related to a vasodilatory effect on the efferent arteriole or vaso-constrictive effect on the afferent arteriole.”
Bakris, G. L., & Weir, M. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.685 · Cited by 823 · cited 2×
“73,78,79 Yet, the long-term effect of diet-induced renal hemodynamic alterations (and its amelioration), independent of e.g. , an increased renal acid load, on renal outcome in diabetes remains unclear.”
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Glomerular hyperfiltration: definitions, mechanisms and clinical implications
Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.19 · Cited by 673
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Levey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620 · cited 1×
“However, especially as hyper fi ltration and albuminuria are renal hemodynamically linked, 76 dedicated prospective studies are needed to con fi rm whether targeting hyper fi ltration improves clinically relevant end points ( i.e. , 30% or 40% eGFR decline, 120 ESRD, and/or renal death).”
Glomerular hemodynamics in severe obesity
Chagnac, A., Weinstein, T., Korzets, A., Ramadan, E., Hirsch, J., & Gafter, U. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f817 · Cited by 614
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
Brenner, P. D. B. M. (1983) · Kidney International · doi:10.1038/ki.1983.72 · Cited by 614
Measured GFR as a Confirmatory Test for Estimated GFR
Stevens, L. A., & Levey, A. S. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009020171 · Cited by 602 · cited 7×
“Hyper fi ltra-tion per se does not seem to fully explain adverse renal outcome, as the risk for ESRD in transplant donors (in which 32,48,123 – 126 are suggested to result in a net reduction in afferent arteriolar resistance, thereby increasing (single-nephron) GFR. Effects of insulin per se seem to depend on insulin s…”
InfluentialFunctional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
The Effects of Weight Loss on Renal Function in Patients with Severe Obesity
Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., & Ori, Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068462.38661.89 · Cited by 541
Obesity, hypertension, and chronic kidney disease
Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520
Avosentan for Overt Diabetic Nephropathy
Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., & Viberti, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060593 · Cited by 492
Measuring GFR: A Systematic Review
Soveri, I., Berg, U. B., Björk, J., Elinder, C.-G., Grubb, A., Mejare, I., Sterner, G., & Bäck, S.-E. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.04.010 · Cited by 491
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Epstein, M., Williams, G. H., Weinberger, M., Lewin, A., Krause, S., Mukherjee, R., Patni, R., & Beckerman, B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240106 · Cited by 459
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
Grams, M. E., Sang, Y., Levey, A. S., Matsushita, K., Ballew, S., Chang, A. R., Chow, E. K. H., Kasiske, B. L., Kovesdy, C. P., Nadkarni, G. N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510491 · Cited by 454
Glucagon-Like Peptide 1 Induces Natriuresis in Healthy Subjects and in Insulin-Resistant Obese Men
Gutzwiller, J.-P., Tschopp, S., Bock, A., Zehnder, C. E., Huber, A. R., Kreyenbuehl, M., Gutmann, H., Drewe, J., Henzen, C., Goeke, B., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031403 · Cited by 442 · cited 1×
“87 The long-acting GLP-1RA liraglutide reversibly reduced measured GFR and UAE in an uncontrolled open-label study involving 31 patients with T2DM.”
Holtkamp, F. A., de Zeeuw, D., Thomas, M. C., Cooper, M. E., de Graeff, P. A., Hillege, H. J. L., Parving, H.-H., Brenner, B. M., Shahinfar, S., & Lambers Heerspink, H. J. (2011) · Kidney International · doi:10.1038/ki.2011.79 · Cited by 364
Glomerular Hyperfiltration in Experimental Diabetes Mellitus: Potential Role of Tubular Reabsorption
VALLON, V., RICHTER, K., BLANTZ, R. C., THOMSON, S., & OSSWALD, H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122569 · Cited by 356
The biology of renal hypertrophy
Fine, L. (1986) · Kidney International · doi:10.1038/ki.1986.45 · Cited by 349 · cited 1×
“45 However, in animal studies, hypertrophy precedes hyper fi ltration.”
Magee, G. M., Bilous, R. W., Cardwell, C. R., Hunter, S. J., Kee, F., & Fogarty, D. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1268-0 · Cited by 345
8. Cardiovascular Disease and Risk Management
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s011 · Cited by 329
Increased Kidney Size and Glomerular Filtration Rate in Early Juvenile Diabetes
Mogensen, C. E., & Andersen, M. J. F. (1973) · Diabetes · doi:10.2337/diab.22.9.706 · Cited by 328 · cited 1×
“11,42 Although increased kidney size 36,43 and fi ltration surface area per glomerulus 44 have been linked to hyper-fi ltration, it has been proven dif fi cult to separate cause from effect.”
Christiansen, J. S., Gammelgaard, J., Frandsen, M., & Parving, H.-H. (1981) · Diabetologia · doi:10.1007/bf00253406 · Cited by 323
Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100854 · Cited by 323 · cited 1×
“…on the basis of serum cystatin C is suggested to more accurately re fl ect renal function in patients with diabetes and normal or elevated GFR. 17,18 Never-theless, renal clearance techniques using inulin, or its more widely used alternative sinistrin, are required for gold standard measurement…”
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Ruggenenti, P., Porrini, E. L., Gaspari, F., Motterlini, N., Cannata, A., Carrara, F., Cella, C., Ferrari, S., Stucchi, N., Parvanova, A., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2189 · Cited by 321
Combined Renal Effects of Overweight and Hypertension
Ribstein, J., du Cailar, G., & Mimran, A. (1995) · Hypertension · doi:10.1161/01.hyp.26.4.610 · Cited by 314 · cited 1×
“36 Notably, independent of diabetes and glucose levels, 37 body weight also augments GFR (by about 15% in obese 37 to about 56% in severely obese nondiabetic subjects 38,39 ).”
de Zeeuw, D., Coll, B., Andress, D., Brennan, J. J., Tang, H., Houser, M., Correa-Rotter, R., Kohan, D., Lambers Heerspink, H. J., Makino, H., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080830 · Cited by 302 · cited 6×
“116 In line with these hemodynamic observations, long-term treatment with endothelin-A receptor antagonists reduced residual albuminuria by 35% – 50% and seemingly preserved renal function in patients with T2DM that were optimally treated for their DKD. 117,118 As the anti-proteinuric effect of this drug class is alre…”
InfluentialSelf-citationRenal Functional Reserve and Renal Recovery after Acute Kidney Injury
Sharma, A., Mucino, M. J., & Ronco, C. (2014) · Nephron Clinical Practice · doi:10.1159/000363721 · Cited by 296 · cited 1×
“31 In early diabetes, when nephron mass is still .”
Rudberg, S., Persson, B., & Dahlquist, G. (1992) · Kidney International · doi:10.1038/ki.1992.126 · Cited by 296
Wiseman, M. J., Saunders, A. J., Keen, H., & Viberti, G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503073121004 · Cited by 266 · cited 1×
“73 m(2) (16% reduction) in patients with T1DM on insulin pump therapy, whereas no effect on GFR was observed in the control group that continued conventional insulin treatment without changes in HbA1c.(36) Notably, independent of diabetes and glucose levels,37 body weight also augments GFR (by about 15% in obese37”
Pathophysiology of the Diabetic Kidney
Vallon, V., & Komers, R. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100049 · Cited by 259 · cited 8×
“32,42,51 54 Finally, diabetes-associated tubular hyperplasia and hypertrophy 32 and proximal tubular hyper-reabsorption reduce intratubular pressure and hydraulic pressure in Bowman ’ s space, which further perpet-uates hyper fi ltration by increasing the net hydraulic pressure gradient.”
InfluentialAdverse renal consequences of obesity
Griffin, K. A., Kramer, H., & Bidani, A. K. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00324.2007 · Cited by 256
Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy
Mogensen, C. E. (1986) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518609083660 · Cited by 255
EVALUATION OF RENAL RESISTANCES, WITH SPECIAL REFERENCE TO CHANGES IN ESSENTIAL HYPERTENSION 1
Gómez, D. M. (1951) · Journal of Clinical Investigation · doi:10.1172/jci102534 · Cited by 252
Thomson, S. C., Deng, A., Bao, D., Satriano, J., Blantz, R. C., & Vallon, V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10963 · Cited by 236
Kohan, D. E., Pritchett, Y., Molitch, M., Wen, S., Garimella, T., Audhya, P., & Andress, D. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080869 · Cited by 236 · cited 1×
“117,119 CONCLUDING REMARKS CKD due to diabetes continues to rise, indicating that current strategies in managing DKD do not suf fi ce to halt renal risk in this population.”
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
Porrini, E., Ruggenenti, P., Mogensen, C. E., Barlovic, D. P., Praga, M., Cruzado, J. M., Hojs, R., Abbate, M., & de Vries, A. P. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00094-7 · Cited by 232
Mogensen, C. E., & Andersen, M. J. F. (1975) · Diabetologia · doi:10.1007/bf00422325 · Cited by 224 · cited 1×
“Although glucose-lowering per se ameliorates diabetic hyper fi ltration, especially in early-onset diabetes, 80 some antihyperglycemic drugs exhibit glu-cose-independent properties that may directly and/or indirectly bene fi t this renal risk factor.”
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 215
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
de Paula, R. B., da Silva, A. A., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000105624.68174.00 · Cited by 207
The Glomerulus: The Sphere of Influence
Pollak, M. R., Quaggin, S. E., Hoenig, M. P., & Dworkin, L. D. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09400913 · Cited by 203
The clinical significance of hyperfiltration in diabetes
Jerums, G., Premaratne, E., Panagiotopoulos, S., & MacIsaac, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1794-9 · Cited by 198
Chagnac, A., Herman, M., Zingerman, B., Erman, A., Rozen-Zvi, B., Hirsh, J., & Gafter, U. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn379 · Cited by 195 · cited 3×
“32,42,51 54 Finally, diabetes-associated tubular hyperplasia and hypertrophy 32 and proximal tubular hyper-reabsorption reduce intratubular pressure and hydraulic pressure in Bowman ’ s space, which further perpet-uates hyper fi ltration by increasing the net hydraulic pressure gradient.”
Goddard, J., Johnston, N. R., Hand, M. F., Cumming, A. D., Rabelink, T. J., Rankin, A. J., & Webb, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000118499.69469.51 · Cited by 194 · cited 1×
“116 In line with these hemodynamic observations, long-term treatment with endothelin-A receptor antagonists reduced residual albuminuria by 35% – 50% and seemingly preserved renal function in patients with T2DM that were optimally treated for their DKD. 117,118 As the anti-proteinuric effect of…”
Cachat, F., Combescure, C., Cauderay, M., Girardin, E., & Chehade, H. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03080314 · Cited by 191
The Early Natural History of Nephropathy in Type 1 Diabetes
Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., & for the International Diabetic Nephropathy Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2164 · Cited by 190
Bariatric surgery is associated with improvement in kidney outcomes
Chang, A. R., Chen, Y., Still, C., Wood, G. C., Kirchner, H. L., Lewis, M., Kramer, H., Hartle, J. E., Carey, D., Appel, L. J., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.039 · Cited by 187 · cited 2×
“77 As humans largely reside in the postprandial state, the excessive and prolonged metabolic and hormonal disturbances occurring after meal ingestion in diabetes could, in theory, unfavorably in-fl uence kidney function, and predispose to renal damage.”
Pessoa, T. D., Campos, L. C. G., Carraro-Lacroix, L., Girardi, A. C. C., & Malnic, G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060588 · Cited by 184 · cited 1×
“81 Thus, SGLT2 inhibition could reduce (single-nephron) hyper fi ltration in diabetes by ( 1 ) restoring sodium-chloride concentration at the macula densa and subsequent TGF-mediated afferent arteriolar vasoconstriction, 82,83 and ( 2 ) increasing intraluminal volume causing a retrograde increase in…”
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
Muskiet, M. H. A., Smits, M. M., Morsink, L. M., & Diamant, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.272 · Cited by 181 · cited 4×
“…a GLP-1 – mediated inhibition of NHE3 (which assembles with DPP-4 in the proximal tubular brush border), thereby reducing proximal sodium reabsorption and GFR through activation of TGF. 51 However, acute administration of GLP-1RA left GFR unaffected in patients with T2DM with normal renal function.”
InfluentialSelf-citationVallon, V., Blantz, R. C., & Thomson, S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051700.07403.27 · Cited by 166
Pistrosch, F., Herbrig, K., Kindel, B., Passauer, J., Fischer, S., & Gross, P. A. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2206 · Cited by 163
The GFR and GFR decline cannot be accurately estimated in type 2 diabetics
Gaspari, F., Ruggenenti, P. L., Porrini, E., Motterlini, N., Cannata, A. N., Carrara, F., Jiménez, A., Cella, C., Ferrari, S., Stucchi, N., et al. (2013) · Kidney International · doi:10.1038/ki.2013.47 · Cited by 159
Amin, R., Turner, C., Aken, S. V., Bahu, T. K., Watts, A., Lindsell, D. R., Dalton, R. N., & Dunger, D. B. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00590.x · Cited by 159
Škrtić, M., Yang, G. K., Perkins, B. A., Soleymanlou, N., Lytvyn, Y., von Eynatten, M., Woerle, H. J., Johansen, O. E., Broedl, U. C., Hach, T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3396-4 · Cited by 159 · cited 2×
“82,83 Finally, as the rise in circulating RAS components may have blunted the renal hemodynamic effect of empagli fl ozin in these RAS blockade naïve T1DM patients, it is tempting to speculate that combined use of SGLT2 inhibitors and angiotensin converting enzyme inhibitors/ARBs may lead to…”
Renal hyperfiltration related to diabetes mellitus and obesity in human disease
Sasson, A. N. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.1 · Cited by 158
Effects of a New SGLT2 Inhibitor, Luseogliflozin, on Diabetic Nephropathy in T2DN Rats
Kojima, N., Williams, J. M., Takahashi, T., Miyata, N., & Roman, R. J. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203869 · Cited by 153 · cited 1×
“84 Surprisingly, FF increased during euglycemic-clamp conditions in the hyper fi ltering patients, underlining the dif fi culty to unambiguously assess intrarenal hemodynamic changes.”
Everything we always wanted to know about furosemide but were afraid to ask
Huang, X., Mees, E. J. D., Vos, P. F., Hamza, S., & Braam, B. G. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00476.2015 · Cited by 153 · cited 1×
“111 Thiazide diuretics and epithelial sodium channel blockers act distally of the macula densa and do not in fl uence TGF signals.”
The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
Wahren, J., Kallas, Å., & Sima, A. A. F. (2012) · Diabetes · doi:10.2337/db11-1423 · Cited by 150
Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus
Vora, J. P., Dolben, J., Dean, J. D., Thomas, D. M., Williams, J. D., Owens, D. R., & Peters, J. R. (1992) · Kidney International · doi:10.1038/ki.1992.127 · Cited by 148
An autopsy study suggests that diabetic nephropathy is underdiagnosed
Klessens, C. Q. F., Woutman, T. D., Veraar, K., Zandbergen, M., Valk, E. J. J., Rotmans, J. I., Wolterbeek, R., BRUIJN, J. A., & Bajema, I. M. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.023 · Cited by 145
Wuerzner, G., Pruijm, M. T., Maillard, M. P., Bovet, P., Renaud, C. J., Burnier, M., & Bochud, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.017 · Cited by 135 · cited 1×
“105 The rationale for BSA adjustments comes from observations in mammals that GFR and ERPF are proportional to kidney size, which in turn is typically proportional to body size.”
KINEBUCHI, S.-I., KAZAMA, J. J., SATOH, M., SAKAI, K., NAKAYAMA, H., YOSHIZAWA, H., NARITA, I., SUZUKI, E., & GEJYO, F. (2004) · Clinical Science · doi:10.1042/cs20040074 · Cited by 133
The potential for renoprotection with incretin-based drugs
Tanaka, T., Higashijima, Y., Wada, T., & Nangaku, M. (2014) · Kidney International · doi:10.1038/ki.2014.236 · Cited by 133
Renal findings in patients with short-term type 2 diabetes.
Keller, C. K., Bergis, K. H., Fliser, D., & Ritz, E. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122627 · Cited by 133
Impact of Renin Angiotensin System Modulation on the Hyperfiltration State in Type 1 Diabetes
Sochett, E. B., Cherney, D. Z. I., Curtis, J. R., Dekker, M. G., Scholey, J. W., & Miller, J. A. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080872 · Cited by 131
Kwong, Y.-T. (., Stevens, L. A., Selvin, E., Zhang, Y. (., Greene, T., Van Lente, F., Levey, A. S., & Coresh, J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.02.347 · Cited by 130 · cited 1×
“10,13 Identi fi cation of hyper fi l-tration in clinical practice and systematic studies is complicated by intra-and interday GFR fl uctuations, 14,15 and the inaccuracy of available serum creatinine – based GFR estimates.”
Effects of insulin-like growth factor I on renal function in normal men
Hirschberg, R. R., Brunori, G., Kopple, J. D., & Guler, H. (1993) · Kidney International · doi:10.1038/ki.1993.57 · Cited by 129
Skov, J., Pedersen, M., Holst, J. J., Madsen, B., Goetze, J. P., Rittig, S., Jonassen, T., Frøkiær, J., Dejgaard, A., & Christiansen, J. S. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12651 · Cited by 128
Tonneijck, L., Smits, M. M., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., & van Raalte, D. H. (2016) · Diabetologia · doi:10.1007/s00125-016-3938-z · Cited by 126
Self-citationPharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck, B., Brandau, W., Weber, E., Kälble, T., Parekh, N., & Georgi, P. (1990) · PubMed · Cited by 118
Gilbert, R. E. (2013) · Kidney International · doi:10.1038/ki.2013.451 · Cited by 117 · cited 1×
“85 In EMPA-REG OUTCOME, 48 months of empagli fl ozin versus placebo treatment in 7020 high-risk patients with T2DM induced an eGFR trajectory reminiscent of RAS blockade (Figure 5), and resulted in a 46% reduction in the composite of serum creatinine doubling (accompanied by eGFR of # 45 ml/min per…”
Tonneijck, L., Smits, M. M., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., ter Wee, P. M., Diamant, M., Joles, J. A., & van Raalte, D. H. (2016) · Diabetes Care · doi:10.2337/dc16-1371 · Cited by 113 · cited 1×
“91 However, although 12-weeks ’ liraglutide treatment nonsigni fi cantly reduced mean GFR of 75 by 5 ml/min per 1.73 m 2 in 27 albuminuric patientswithT2DMwithalbuminuria,ina placebo-controlled crossover study, GFR decreased by .”
InfluentialSelf-citationBjornstad, P., Cherney, D. Z., Snell-Bergeon, J. K., Pyle, L., Rewers, M., Johnson, R. J., & Maahs, D. M. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv121 · Cited by 111
Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea
Bankir, L., Roussel, R., & Bouby, N. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00614.2014 · Cited by 111 · cited 8×
“88 These observations have been attributed to a GLP-1 – mediated inhibition of NHE3 (which assembles with DPP-4 in the proximal tubular brush border), thereby reducing proximal sodium reabsorption and GFR through activation of TGF. 51 However, acute administration of GLP-1RA left GFR unaffected in patients with T2DM w…”
InfluentialDahlquist, G., Stattin, E., & Rudberg, S. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1382 · Cited by 106
Effect of a High-Protein Diet on Kidney Function in Healthy Adults: Results From the OmniHeart Trial
Juraschek, S. P., Appel, L. J., Anderson, C. A. M., & Miller, E. R. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.10.017 · Cited by 105 · cited 1×
“102 Furthermore, guidelines direct to reduce sodium intake to , 2000 mg/d in order to prevent renal disease in diabetes.”
The effect of liraglutide on renal function: A randomized clinical trial
von Scholten, B. J., Persson, F., Rosenlund, S., Hovind, P., Faber, J., Hansen, T. W., & Rossing, P. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12808 · Cited by 105 · cited 1×
“92 Of future interest are postprandial renal hemodynamic actions of short-acting GLP-1RA(whichhavesustainedinhibitory effectsongastricemptyingrateandgluca-gonlevels)orDPP-4inhibitors.”
Premaratne, E., MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T., & Jerums, G. (2005) · Diabetologia · doi:10.1007/s00125-005-0002-9 · Cited by 102
Melsom, T., Schei, J., Stefansson, V. T. N., Solbu, M. D., Jenssen, T. G., Mathisen, U. D., Wilsgaard, T., & Eriksen, B. O. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.10.025 · Cited by 102 · cited 1×
“34 As such, prevalence of diabetes-related hyper fi ltration may have been dropped due to earlier diagnosis and modern day stricter control of hyperglycemia and other factors ( e.g. , angiotensin II by means of RAS blockade).”
Zerbini, G., Bonfanti, R., Meschi, F., Bognetti, E., Paesano, P. L., Gianolli, L., Querques, M., Maestroni, A., Calori, G., Del Maschio, A., et al. (2006) · Diabetes · doi:10.2337/db06-0592 · Cited by 101
Michell, A. R., Debnam, E. S., & Unwin, R. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.040705.141330 · Cited by 95 · cited 1×
“…factors may be released or activated after a (high-protein) meal ( e.g. , nitric oxide, cyclooxygenase-2 prostanoids, angiotensin II), 48,50,130 whereas TGF becomes (further) inhibited, through increased amino acid-(and glucose) coupled sodium reabsorption in the proximal tubule 49,50…”
Serri, O., Beauregard, H., Brazeau, P., Abribat, T., Lambert, J., Harris, A. A., & Vachon, L. (1991) · JAMA · doi:10.1001/jama.1991.03460070070045 · Cited by 93
Lervang, H.-H., Jensen, S., Brøchner‐Mortensen, J., & Ditzel, J. (1988) · Diabetologia · doi:10.1007/bf00274773 · Cited by 90
Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Heerspink, H. J. L., & van Raalte, D. H. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00030-3 · Cited by 90 · cited 5×
“76 However, clinicians may be reluctant to advocate sodium restriction in diabetes.”
InfluentialSelf-citationCherney, D. Z. I., Miller, J. A., Scholey, J. W., Bradley, T. J., Slorach, C., Curtis, J. R., Dekker, M. G., Nasrallah, R., Hébert, R. L., & Sochett, E. B. (2008) · Diabetes · doi:10.2337/db07-1230 · Cited by 90
Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
Ficociello, L. H., Perkins, B. A., Roshan, B., Weinberg, J. M., Aschengrau, A., Warram, J. H., & Krolewski, A. S. (2009) · Diabetes Care · doi:10.2337/dc08-1560 · Cited by 89
Tubular reabsorption and diabetes‐induced glomerular hyperfiltration
Persson, P., Hansell, P., & Palm, F. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02147.x · Cited by 88
Glomerular Hyperfiltration in the Prediction of Nephropathy in IDDM: A 10-Year Follow-Up Study
Yip, J. W., Jones, S. L., Wiseman, M. J., Hill, C., & Viberti, G. (1996) · Diabetes · doi:10.2337/diab.45.12.1729 · Cited by 88
Hirose, K., Tsuchida, H., Østerby, R., & Hj, G. (1980) · PubMed · Cited by 88
Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli
Denton, K. M., Fennessy, P. A., Alcorn, D., & Anderson, W. P. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.262.3.f367 · Cited by 88 · cited 2×
“32,42,71,124,127 Growth hormone 128 and insulin-like growth factor-1 129 likely increase fi ltration by augmenting total renal blood fl ow, without speci fi c arteriolar preference.”
Low Birth Weight: A Risk Factor for Development of Diabetic Nephropathy?
Rossing, P. R., Tarnow, L., Nielsen, F. S., Hansen, B. V., Brenner, B. M., & Parving, H. (1995) · Diabetes · doi:10.2337/diab.44.12.1405 · Cited by 87 · cited 1×
“11 Notably, use of any set GFR cutoff does not consider differences between sexes and distinct ethnic populations, 10 nephron endowment at birth, 12 and age-related GFR decline.”
Blood pressure changes and renal function in incipient and overt diabetic nephropathy.
Mogensen, C. E., & Christensen, C. (1985) · Hypertension · doi:10.1161/01.hyp.7.6_pt_2.ii64 · Cited by 84
Guo, K., Zhang, L., Zhao, F., Lu, J., Pan, P., Yu, H., Bao, Y., Chen, H., & Jia, W. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.020 · Cited by 84
Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children
Chiarelli, F., Verrotti, A., & Morgese, G. (1995) · Pediatric Nephrology · doi:10.1007/bf00860729 · Cited by 83 · cited 1×
“69,70 In a post hoc analysis of 600 patients with T2DM, patients with persistent measured hyper fi ltration, compared with those with normo fi ltration at inclusion or in whom hyper fi ltration was ameliorated by metabolic and BP control at 6 months, were more likely to develop microalbuminuria or…”
Vervoort, G., Veldman, B., Berden, J. H. M., Smits, P., & Wetzels, J. F. M. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01497.x · Cited by 81
Renal Enlargement Precedes Renal Hyperfiltration in Early Experimental Diabetes in Rats
Bak, M., Thomsen, K., Christiansen, T., & Flyvbjerg, A. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171287 · Cited by 81
Viswanathan, V., Tilak, P., & Kumpatla, S. (2012) · PubMed Central · Cited by 80
Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats
Luippold, G. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg584 · Cited by 77
Silveiro, S. P., Friedman, R., de Azevedo, M. J., Canani, L. H. S., & Gross, J. L. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.171 · Cited by 76
Hyperfiltration Affects Accuracy of Creatinine eGFR Measurement
Huang, S. S., Sharma, A. P., Yasin, A., Lindsay, R. M., Clark, W. F., & Filler, G. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02760310 · Cited by 73
von Scholten, B. J., Hansen, T. W., Goetze, J. P., Persson, F., & Rossing, P. R. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.04.004 · Cited by 72
Christiansen, J. S., Gammelgaard, J., Frandsen, M., �rskov, H., & Parving, H. ‐. (1982) · Diabetologia · doi:10.1007/bf00253577 · Cited by 69
McAdam, B. F., Byrne, D. W., Morrow, J. D., & Oates, J. A. (2005) · Circulation · doi:10.1161/circulationaha.105.542696 · Cited by 69
Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor
Holst, J. J., & Madsbad, S. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.033 · Cited by 67
The Natural History of Residual Renal Function in Transplant Donors
Mueller, T., & Luyckx, V. A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111080 · Cited by 66 · cited 1×
“57 is very low.”
Role of protein kinase C in angiotensin II-induced constriction of renal microvessels
Nagahama, T., Hayashi, K., Ozawa, Y., Takenaka, T., & Saruta, T. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00822.x · Cited by 65
Bangstad, H. ‐., Østerby, R., Rudberg, S. L., Hartmann, A., Brabrand, K., & Hanssen, K. F. (2002) · Diabetologia · doi:10.1007/s00125-001-0744-y · Cited by 64
Effects of dietary interventions on incidence and progression of CKD
Jain, N., & Reilly, R. F. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.192 · Cited by 63 · cited 1×
“101 As such, in (pre)hypertensive patients of the OmniHeart study, a high-protein diet (+10% of energy from protein) increased fasting eGFR by approximately 4 ml/min per 1.73 m 2 compared with diets replacing protein with either carbohydrate or fat.”
InfluentialRenal Stress Testing in the Assessment of Kidney Disease
Chawla, L. S., & Ronco, C. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.04.005 · Cited by 60
Improving the efficacy of RAAS blockade in patients with chronic kidney disease
Heerspink, H. J. L., de Borst, M. H., Bakker, S. J. L., & Navis, G. J. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.281 · Cited by 59
Self-citationHypertrophy and hyperfunction of the diabetic kidney
Hostetter, T. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12066 · Cited by 59
Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy
Hansen, H. P., Hovind, P. H., Jensen, B. R., & Parving, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00092.x · Cited by 58 · cited 1×
“10,13 Identi fi cation of hyper fi l-tration in clinical practice and systematic studies is complicated by intra-and interday GFR fl uctuations, 14,15 and the inaccuracy of available serum creatinine – based GFR estimates.”
Kinin, a Mediator of Diabetes-Induced Glomerular Hyperfiltration
Jaffa, A. A., Rust, P. F., & Mayfield, R. K. (1995) · Diabetes · doi:10.2337/diab.44.2.156 · Cited by 58 · cited 1×
“Hyper fi ltra-tion per se does not seem to fully explain adverse renal outcome, as the risk for ESRD in transplant donors (in which 32,48,123 – 126 are suggested to result in a net reduction in afferent arteriolar resistance, thereby increasing (single-nephron) GFR. Effects of insulin per se seem to…”
Salt intake in kidney disease--a missed therapeutic opportunity?
Lambers Heerspink, H. J., Navis, G., & Ritz, E. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs354 · Cited by 57
Self-citationRenal Hemodynamics in Recent-Onset Type II Diabetes
Nowack, R., Raum, E., Blum, W. F., & Ritz, E. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70296-2 · Cited by 56
Zhang, P. L., Mackenzie, H. S., Troy, J. L., & Brenner, B. M. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v481564 · Cited by 56
Potential mechanisms mediating postprandial renal hyperemia and hyperfiltration
Premen, A. J. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277887 · Cited by 55 · cited 3×
“…vascular factors may be released or activated after a (high-protein) meal ( e.g. , nitric oxide, cyclooxygenase-2 prostanoids, angiotensin II), 48,50,130 whereas TGF becomes (further) inhibited, through increased amino acid-(and glucose) coupled sodium reabsorption in the proximal tubule 49,50…”
Chaiken, R. L., Eckert‐Norton, M., Bard, M., Banerji, M. A., Palmisano, J. J., Sachimechi, I., & Lebovitz, H. E. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2129 · Cited by 55
Effects of preglomerular and postglomerular vascular resistance alterations on filtration fraction.
Carmines, P. K., Perry, M. D., Hazelrig, J. B., & Navar, L. G. (1987) · PubMed · Cited by 55
Couper, J., Clarke, C. F., Byrne, G. C., Jones, T. W., Donaghue, K. C., Nairn, J., Boyce, D., Russell, M., Stephens, M., Raymond, J., et al. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199709)14:9<762::aid-dia485>3.0.co;2-c · Cited by 54
Morales, E., Millet, V. G., Rojas-Rivera, J., Huerta, A., Gutierrez, E., Gutierrez-Solis, E., Egido, J., & Praga, M. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs429 · Cited by 54 · cited 2×
“114 Endothelin-A Receptor Antagonists Increased endothelin-1 concentrations contribute to DKD development by increasing P GLO , podocyte damage, and permeability to albumin.”
Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial
Zingerman, B., Herman-Edelstein, M., Erman, A., Bar Sheshet Itach, S., Ori, Y., Rozen-Zvi, B., Gafter, U., & Chagnac, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137163 · Cited by 52
Obesity, Glomerular Hyperfiltration, and the Surface Area Correction
Levey, A. S., & Kramer, H. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.06.005 · Cited by 51 · cited 3×
“106 In addition, formulas like the Du Bois and Du Bois may not be accurate in severely obese (T2DM) subjects.”
InfluentialMurussi, M., Campagnolo, N., Beck, M., Gross, J. L., & Silveiro, S. P. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02209.x · Cited by 50
Viberti, G. C. (1991) · Diabetologia · doi:10.1007/bf00404027 · Cited by 50
Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?
on behalf of the FinnDiane Study Group, Thomas, M. C., Moran, J. L., Harjutsalo, V., Thorn, L. M., Wadén, J., Saraheimo, M., Tolonen, N., Leiviskä, J., Jula, A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2485-5 · Cited by 49
The Gomez equations and renal hemodynamic function in kidney disease research
Bjornstad, P., Škrtić, M., Lytvyn, Y., Maahs, D. M., Johnson, R. J., & Cherney, D. Z. I. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2016 · Cited by 47
Glomerular Hyperfiltration in NIDDM Patients Without Overt Proteinuria
Silveiro, S. P., Friedman, R., & Gross, J. L. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.115 · Cited by 46
Caramori, M. L., Gross, J. L., Pecis, M., & de Azevedo, M. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1512 · Cited by 45
Biphasic Vasodilator Action of Troglitazone on the Renal Microcirculation
Arima, S., Kohagura, K., Takeuchi, K., Taniyama, Y., Sugawara, A., Ikeda, Y., Abe, M., Omata, K., & Ito, S. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132342 · Cited by 45
Inhibiting or antagonizing glucagon: making progress in diabetes care
Lefèbvre, P. J., Paquot, N., & Scheen, A. J. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12480 · Cited by 44 · cited 1×
“48,99 Interestingly, glucagon levels increase in the course of DKD. 100 Selective blockade of the glucagon receptor as a novel glucose-lowering target in diabetes could favorably in fl uence renal hemodynamics.”
Murussi, M., Gross, J. L., & Silveiro, S. P. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.07.002 · Cited by 43
Yokoyama, H., Kanno, S., Takahashi, S., Yamada, D., Honjo, J., Saito, K., Sone, H., & Haneda, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq774 · Cited by 42
Cherney, D. Z. I., Sochett, E. B., Dekker, M. G., & Perkins, B. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03121.x · Cited by 41 · cited 6×
“Hyper fi ltra-tion per se does not seem to fully explain adverse renal outcome, as the risk for ESRD in transplant donors (in which 32,48,123 – 126 are suggested to result in a net reduction in afferent arteriolar resistance, thereby increasing (single-nephron) GFR. Effects of insulin per se seem to depend on insulin s…”
InfluentialAngiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes
Tikellis, C., Brown, R., Head, G. A., Cooper, M. E., & Thomas, M. C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00264.2013 · Cited by 41
The Risks of Living Kidney Donation
Steiner, R. W. (2015) · New England Journal of Medicine · doi:10.1056/nejme1513891 · Cited by 40 · cited 1×
“58 However, it may be suggested that the stimulus and/or prevailing diabetes play a part in the pathogenesis of hyper fi ltration-induced renal damage.”
Cherney, D. Z. I., Konvalinka, A., Zinman, B., Diamandis, E. P., Soosaipillai, A., Reich, H., Lorraine, J., Lai, V., Scholey, J. W., & Miller, J. A. (2009) · Diabetes Care · doi:10.2337/dc08-1609 · Cited by 40
Amino acid transport in the renal proximal tubule
Gonska, T. Y., Hirsch, J. R., & Schlatter, E. (2000) · Amino Acids · doi:10.1007/s007260070019 · Cited by 36
Hannedouche, T. P., Lázaro, M. B., Delgado, A. G., Boîtard, C., Lacour, B., & Grünfeld, J. (1991) · Clinical Science · doi:10.1042/cs0810457 · Cited by 34
Renal function in black Americans with Type II diabetes
Palmisano, J. J., & Lebovitz, H. E. (1989) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(89)90009-3 · Cited by 33
Increased Hyaluronic Acid in the Inner Renal Medulla of Obese Dogs
Alonso-Galicia, M., Dwyer, T. M., Herrera, G. A., & Hall, J. E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.888 · Cited by 32
Thomson, H. J., Ekinci, E. I., Radcliffe, N. J., Seah, J., MacIsaac, R. J., Jerums, G., & Premaratne, E. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.003 · Cited by 32 · cited 1×
“60,61 64 However, as GFR remained in the normal range at end of follow-up ( i.e. , $ 100 ml/min per 1.73 m 2 ), it is unclear whether these observations indicate (pharmacologic) resolution of hyper fi ltration ( i.e. , restoration of renal functional reserve), or loss of nephron mass.”
InfluentialSk�tt, P., Hommel, E. E., Bruun, N. E., Arnold‐Larsen, S., & Parving, H. ‐. (1988) · Diabetologia · doi:10.1007/bf00277481 · Cited by 30 · cited 4×
“In the classic, fi ve-stage, protei-nuricpathwayofDKD,theinitialphaseis characterized by an absolute, supraphy-siologic increase in whole-kidney GFR ( i.e. , the sum of fi ltration in all functioning nephrons) (Figure 1).”
InfluentialLervang, H.-H., Jensen, S., Brøchner‐Mortensen, J., & Ditzel, J. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01859.x · Cited by 30
Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients
Jin, Y., Moriya, T., Tanaka, K., Matsubara, M., & Fujita, Y. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.06.014 · Cited by 29
Glomerular hyperfiltration in type I, type II, and secondary diabetes
Marre, M., Hallab, M., Roy, J., Lejeune, J.-J., JALLET, P., & Fressinaud, P. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90044-l · Cited by 25
Gragnoli, G., Signorini, A. M., Tanganelli, I., Fondelli, C., Borgogni, P., Borgogni, L., Vattimo, A., Ferrari, F., & Guercia, M. J. D. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187475 · Cited by 24
Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy
Ruggenenti, P., Flores, C., Aros, C., Ene-Iordache, B., Trevisan, R., Ottomano, C., & Remuzzi, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.502 · Cited by 24
Guízar, J.-M., Kornhauser, C., Malacara, J. M., Amador‐Licona, N., Barrera, J. A., & Esparza, R. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045919 · Cited by 22
Insulin‐mediated increases in renal plasma flow are impaired in insulin‐resistant normal subjects
Ter Maaten, J. C., Bakker, S. J. L., Serné, E. H., Moshage, H. J., Donker, A. J. M., & Gans, R. O. B. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00749.x · Cited by 22 · cited 2×
“96,97 A net increase in efferent arteriolar resistance — leading to increased GFR — is proposed for other vascular factors.”
Age as a determinant of glomerular filtration rate in non-insulin-dependent diabetes mellitus
Rius, F., Pizarro, E., Salinas, I., Lucas, A., Sanmartí, A., & Romero, R. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.9.1644 · Cited by 22 · cited 1×
“10,13 Identi fi cation of hyper fi l-tration in clinical practice and systematic studies is complicated by intra-and interday GFR fl uctuations, 14,15 and the inaccuracy of available serum creatinine – based GFR estimates.”
Cross-Sectional Analysis of Renal Function in Black Americans With NIDDM
Lebovitz, H. E., & Palmisano, J. J. (1990) · Diabetes Care · doi:10.2337/diacare.13.11.1186 · Cited by 21
C-Peptide: The Missing Link in Diabetic Nephropathy?
Nordquist, L., & Wahren, J. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.203 · Cited by 20
Mathiesen, E. R., Feldt‐Rasmussen, B., Hommel, E. E., Deckert, T., & Parving, H. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.286 · Cited by 19
Zhao, F., Zhang, L., Lu, J., Guo, K., Wu, M., Yu, H., Zhang, M., Bao, Y., Chen, H., & Jia, W. (2015) · PubMed · Cited by 17
Asakura, J., Hasegawa, H., Takayanagi, K., Shimazu, T., Suge, R., Shimizu, T., Iwashita, T., Tayama, Y., Matsuda, A., Kanozawa, K., et al. (2013) · Nephron Experimental Nephrology · doi:10.1159/000348661 · Cited by 16
Schmidt, A., Pleiner, J., Schaller, G., Roden, M., Dallinger, S., Mayer, G. J., Schmetterer, L. F., & Wolzt, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00320.x · Cited by 16 · cited 2×
“96,97 A net increase in efferent arteriolar resistance — leading to increased GFR — is proposed for other vascular factors.”
Glomerular hyperfiltration in young Polynesians with type 2 diabetes
Bruce, R., Rutland, M. D., & Cundy, T. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90003-5 · Cited by 16
Hyperfiltration in patients with type I diabetes mellitus: a prevalence study.
Cotroneo, P., Manto, A., Todaro, L., Manto, A., Pitocco, D., Saponara, C., Vellante, C., Maussier, M. L., D'Errico, G., Magnani, P., et al. (1998) · PubMed · Cited by 15
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Raalte, D. H., & Diamant, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70167-6 · Cited by 14
Self-citationEffect of Nifedipine and Captopril on Glomerular Hyperfiltration in Normotensive Man
Böhler, J., Woitas, R. P., Keller, E., Reetze-Bonorden, P., & Schollmeyer, P. J. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80540-3 · Cited by 13 · cited 1×
“73,78,79 Yet, the long-term effect of diet-induced renal hemodynamic alterations (and its amelioration), independent of e.g. , an increased renal acid load, on renal outcome in diabetes remains unclear.”
de Azevedo, M. J., & Gross, J. L. (1991) · Diabetologia · doi:10.1007/bf00400283 · Cited by 12
Glucagon secretion is increased in patients with Type 2 diabetic nephropathy
Wang, X., Yang, J., Chang, B., Shan, C., Xu, Y., Zheng, M., Wang, Y., Ren, H., & Chen, L. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.020 · Cited by 12
Glomerular hyperfiltration in Koreans with non-insulin-dependent diabetes mellitus
Lee, K., Park, J. Y., Hwang, R., Hong, S. K., Kim, G. S., Moon, D. H., Kim, S. B., & Park, J.-S. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90434-4 · Cited by 11
Lithium clearance in water immersion-induced natriuresis in humans
Rabelink, T. J., Koomans, H. A., Boer, W. H., van Rijn, J., & Mees, E. J. D. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.66.4.1744 · Cited by 11
Tietze, I. N., Sørensen, S. S., Ivarsen, P., Nielsen, C. B., & Pedersen, E. B. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715050-00012 · Cited by 10 · cited 1×
“73,78,79 Yet, the long-term effect of diet-induced renal hemodynamic alterations (and its amelioration), independent of e.g. , an increased renal acid load, on renal outcome in diabetes remains unclear.”
The prevalence of micro-albuminuria and glomerular hyperfiltration in young patients with IDDM
Kalk, W. J., Osler, C., Taylor, D., Panz, V. R., Esse, J., & Reinach, S. G. (1990) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(90)90025-o · Cited by 8
Slomowitz, L. A., Bérgamo, R. R., Hirschberg, R. R., Grosvenor, M. B., & Kopple, J. D. (1996) · American Journal of Nephrology · doi:10.1159/000169016 · Cited by 8 · cited 1×
“Although acet-azolamide is rarely used as a diuretic because its long-term natriuretic effect is modest, 107 several studies have shown that this drug markedly reduces GFR in T1DM with whole-kidney hyper fi ltra-tion 108,109 and DKD, 110 likely by TGF activation and independent from sodium balance.”
Decrease of Glomerular Hyperfiltration in Short-Term Diabetic Adolescents Without Microalbuminuria
Bognetti, E., Meschi, F., Bonfanti, R., Gianolli, L., & Chiumello, G. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.120 · Cited by 7
Renal 131I-hippuran extraction in man: effects of dopamine
Hutchings, M., Hesse, B., Grönvall, J. L. E., & Olsen, N. V. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.t01-5-01689.x · Cited by 7
Bulum, T., Kolarić, B., Prkačin, I., & Duvnjak, L. S. (2013) · PubMed · Cited by 6
Cited by
Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
Self-citationCKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Metadata
- Authors
- Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Diabetes Center, Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands;
- University Medical Center Groningen (NL)
- University Medical Center Utrecht (NL)
- Corresponding author
- Tonneijck, Lennart
- Muskiet, Marcel H.A.
- Smits, Mark M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2017-01-31
- Volume
- 28
- Issue
- 4
- Pages
- 1023-1039
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC5373460
- OpenAlex
- W2583476095
- Semantic Scholar
- 4a92847d3e0509be6783afdeee43f9b80ceec7a4
- Cited by
- 887
- References
- 189
- Citations by year
- 2026: 87 · 2025: 130 · 2024: 110 · 2023: 109 · 2022: 138 · 2021: 90 · 2020: 89 · 2019: 64 · 2018: 47 · 2017: 22
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glomerular hyperfiltration, diabetic nephropathy, type 1 diabetes, type 2 diabetes, glomerular hemodynamics, ultrafiltrate, nephron mass, diabetic kidney disease progression, renal protection, glomerular ultrastructure
- MeSH terms
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glomerular Filtration Rate, Humans, Kidney Glomerulus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.